Truist raised the firm’s price target on UnitedHealth (UNH) to $365 from $310 and keeps a Buy rating on the shares. UnitedHealth’s 8-K provided a “solid” first look at the company’s estimate of 2026 Star ratings, while the company on Monday reaffirmed its fiscal 2025 adjusted EPS guidance inclusive of the Amedisys deal, the analyst tells investors in a research note. The update is favorable in a backdrop where the industry has seen Star ratings volatility over the past few years, Truist says.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- Early notable gainers among liquid option names on September 9th
- UnitedHealth star data better than some feared, says JPMorgan
- UnitedHealth star ratings data should ease concerns, says Barclays
- UnitedHealth expects most MA members in 4 star or higher plans, shares up 4.5%
- Sight Sciences OMNI Surgical System to be included in UnitedHealthcare coverage